Abstract
Background: Molecular detection methods for HER2/neu gene amplification include fluorescence in situ hybridization (FISH) and competitive PCR. We designed a quantitative PCR system utilizing fluorescent hybridization probes and a competitor that differed from the HER2/neu sequence by a single base change. Methods: Increasing twofold concentrations of competitor were coamplified with DNA from cell lines with various HER2/neu copy numbers at the HER2/neu locus. Competitor DNA was distinguished from the HER2/neu sequence by a fluorescent hybridization probe and melting curve analysis on a fluorescence-monitoring thermal cycler. The percentages of competitor to target peak areas on derivative fluorescence vs temperature curves were used to calculate copy number. Results: Real-time monitoring of the PCR reaction showed comparable relative areas throughout the log phase and during the PCR plateau, indicating that only end-point detection is necessary. The dynamic range was over two logs (2000-250 000 competitor copies) with CVs <20%. Three cell lines (MRC-5, T-47D, and SK-BR-3) were determined to have gene doses of 1, 3, and 11, respectively. Gene amplification was detected in 3 of 13 tumor samples and was correlated with conventional real-time PCR and FISH analysis. Conclusion: Use of relative peak areas allows gene copy numbers to be quantified against an internal competitive control in <1 h. © 2001 American Association for Clinical Chemistry.
Cite
CITATION STYLE
Lyon, E., Millson, A., Lowery, M. C., Woods, R., & Wittwer, C. T. (2001). Quantification of HER2/neu gene amplification by competitive PCR using fluorescent melting curve analysis. Clinical Chemistry, 47(5), 844–851. https://doi.org/10.1093/clinchem/47.5.844
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.